ASML extends losses after cutting sales guidance, Nvidia stock edges higher, and third-quarter earnings at Morgan Stanley top ...
Novocure stock rocketed late Tuesday after the FDA signed off on its treatment for patients with metastatic lung cancer.
Novocure Ltd (NVCR) is up more than +11% after the US FDA approved the company’s Optune Lua to treat metastatic non-small cell lung cancer in adults who have progressed on or after a platinum-based ...
Pre-Market U.S. Stock Movers Novocure (NVCR) soared about +30% in pre-market trading after the U.S. FDA approved its portable lung cancer treatment, Optune Lua. J.B. Hunt Transport Services (JBHT) ...